Cargando…

Safety and patterns of survivorship in recurrent GBM following resection and surgically targeted radiation therapy: Results from a prospective trial

BACKGROUND: Treatment of recurrent glioblastoma (GBM) remains problematic with survival after additional therapy typically less than 12 months. We prospectively evaluated whether outcomes might be improved with resection plus permanent implantation of a novel radiation device utilizing the gamma-emi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Kris, Nakaji, Peter, Thomas, Theresa, Pinnaduwage, Dilini, Wallstrom, Garrick, Choi, Mehee, Zabramski, Joseph, Chen, Clark, Brachman, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629483/ https://www.ncbi.nlm.nih.gov/pubmed/36322102 http://dx.doi.org/10.1093/neuonc/noac133

Ejemplares similares

Resection and Surgically Targeted Radiation Therapy for the Treatment of Larger Recurrent or Newly Diagnosed Brain Metastasis: Results From a Prospective Trial
por: Nakaji, Peter, et al.
Publicado: (2020)

36. A PROSPECTIVE TRIAL OF RESECTION PLUS SURGICALLY TARGETED RADIATION THERAPY FOR BRAIN METASTASIS
por: Brachman, David, et al.
Publicado: (2020)

Re-Irradiation Using Brachytherapy for Recurrent Intracranial Tumors: A Systematic Review and Meta-Analysis of the Literature
por: Choi, Mehee, et al.
Publicado: (2020)

68. FRAMELESS, VAULT-FREE RADIOSURGERY: INITIAL CLINICAL EXPERIENCE WITH THE ZAP-X STEREOTACTIC SYSTEM
por: Flores, Nicholas, et al.
Publicado: (2020)

Dosimetric Impacts of Source Migration, Radioisotope Type, and Decay with Permanent Implantable Collagen Tile Brachytherapy for Brain Tumors
por: Pinnaduwage, Dilini S., et al.
Publicado: (2022)

MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases
por: Wilcox, Jessica, et al.
Publicado: (2021)

CLRM-19 USING FUNCTIONAL PRECISION MEDICINE TO GUIDE CLINICAL TRIAL ENROLLMENT IN GBM
por: Ledford, Aubrey, et al.
Publicado: (2022)

SYST-11 PHASE 2 STUDY OF VAL-083 AND RADIOTHERAPY IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM
por: Chen, Zhongping, et al.
Publicado: (2022)

CLRM-17 USE OF EXTERNAL CONTROL DATA FOR PLANNING AND ANALYZING GBM TRIALS: READY FOR PRIME TIME?
por: Polley, Mei-Yin, et al.
Publicado: (2022)

STMO-03 Surgical resection for precentral gyrus glioma
por: Kijima, Noriyuki, et al.
Publicado: (2020)

DDRE-03. IDH1-MUTANT GBM CELLS ARE HIGHLY SENSITIVE TO COMBINATION OF KDM6A/B AND HDAC INHIBITORS
por: Kayabölen, Alişan, et al.
Publicado: (2021)

73. PREDICTION OF A SECOND LOCAL RECURRENCE IN SURGICALLY TREATED RECURRENT BRAIN METASTASES PATIENTS
por: Tewarie, Ishaan, et al.
Publicado: (2020)

65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES
por: Dankner, Matthew, et al.
Publicado: (2020)

DDRE-23. A COMPREHENSIVE CHARACTERIZATION OF THE GBM LIPIDOME REVEALS A MOLECULARLY-DEFINED SUB-GROUP WITH HEIGHTENED SENSITIVITY TO LIPID PEROXIDATION INDUCED CELL DEATH
por: Morrow, Danielle, et al.
Publicado: (2021)

SYST-02 PHASE ⅡB CLINICAL TRIAL OF NEOADJUVANT CHEMOTHERAPY REVERSING GLIOMA STEM CELLS CHEMORESISTANCE IN NEWLY DIAGNOSED GBM WITH MGMT PROMOTER UNMETHYLATION
por: Dong, Jun, et al.
Publicado: (2022)

69. PERMANENT INTRACAVITARY Cs131 BRACHYTHERAPY FOR PREVIOUSLY-IRRADIATED RECURRENT BRAIN METASTASES: INITIAL CLINICAL AND RADIATION SAFETY EXPERIENCE
por: Moss, Nelson S, et al.
Publicado: (2020)

12. OUTCOMES AFTER SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE AGE OF CHECKPOINT INHIBITOR TREATMENT
por: Morshed, Ramin, et al.
Publicado: (2020)

OTEH-9. scRNA sequencing of proneural GBM avatar model reveals acquisition of oncogenic transcriptional programming and infers a developmental path towards a genomically unstable state
por: Taylor, Brett M, et al.
Publicado: (2021)

Recurrent anti-GBM disease with pulmonary artery aneurysms
por: Dixon, John, et al.
Publicado: (2016)

MET-5 Salvage surgical resection after linac-based stereotactic radiosurgery and radiotherapy for brain metastasis
por: Matsuda, Ryosuke, et al.
Publicado: (2021)

Surgically targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review
por: Odia, Yazmin, et al.
Publicado: (2022)

SURG-03. The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes
por: Newman, William, et al.
Publicado: (2021)

CLRM-08 TARGETING IMMUNE-PAYLOAD TO THE GLIOBLASTOMA TUMOR MICROENVIRONMENT USING A MACROPHAGE-BASED TREATMENT RELYING ON AUTOLOGOUS, GENETICALLY MODIFIED, HEMATOPOIETIC STEM CELL-BASED THERAPY: THE TEM-GBM STUDY (NCT03866109)
por: Eoli, Marica, et al.
Publicado: (2022)

Whole-procedural Radiological Accuracy for Delivering Multi-session Gamma Knife Radiosurgery With a Relocatable Frame System
por: Ma, Lijun, et al.
Publicado: (2014)

MET-01 Linac-based fractionated stereotactic radiotherapy with micro-multileaf collimeter for large brain metastasis unsuitable for surgical resection
por: Matsuda, Ryosuke, et al.
Publicado: (2020)

MLTI-06. Surgical resection plus stereotactic radiosurgery versus SRS alone for large brain metastases: a comparative study
por: Gutierrez, Enrique, et al.
Publicado: (2021)

LOCL-06 SUPERVISED MACHINE LEARNING IDENTIFIES RISK FACTORS ASSOCIATED WITH LEPTOMENINGEAL DISEASE AFTER SURGICAL RESECTION OF BRAIN METASTASES
por: Morshed, Ramin, et al.
Publicado: (2022)

Fear of cancer recurrence trajectory during radiation treatment and follow-up into survivorship of patients with breast cancer
por: Yang, Y., et al.
Publicado: (2018)

SURG-04. Surgical resection of symptomatic brain metastasis in patients with non-small cell lung cancer irrespective from lesion count
por: Jünger, Stephanie T, et al.
Publicado: (2021)

Clinical management of seizures in patients with meningiomas: Efficacy of surgical resection for seizure control and patient-tailored postoperative anti-epileptic drug management
por: Peart, Rodeania, et al.
Publicado: (2023)

Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme
por: Fuller, Clifton D, et al.
Publicado: (2007)

Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
por: Louie, Thomas J., et al.
Publicado: (2012)

Integrating Survivorship Care Into a Radiation Medicine Program
por: Malam, Shaziya, et al.
Publicado: (2020)

SURG-01. Management of solitary brain metastasis less than 4 cm in diameter. Surgical resection versus stereotactic radiotherapy: a meta-analysis
por: Krist, David T, et al.
Publicado: (2021)

Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids
por: Harrington, Amanda, et al.
Publicado: (2020)

Machine performance and stability of the first clinical self‐shielded stereotactic radiosurgery system: Initial 2‐year experience
por: Srivastava, Shiv P., et al.
Publicado: (2022)

Radiation’s formulations
por: Rogers, C Leland
Publicado: (2022)

Radiation Therapy After Surgical Resection Improves Outcomes for Patients With Recurrent Pleomorphic Adenoma
por: Nicholas, Sarah E., et al.
Publicado: (2021)

Anti-GBM-Nephritis
por: Windpessl, Martin, et al.
Publicado: (2023)

NEIM-03 A MULTICENTER PHASE 3 TRIAL IN PROGRESS: DIAGNOSTIC PERFORMANCE OF(18)F-FLUCICLOVINE PET FOR THE DETECTION OF RECURRENT BRAIN METASTASES AFTER RADIATION THERAPY (REVELATE)
por: Chao, Samuel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vdd0kko0m1t2sggb80htqr94jn